Provided by Tiger Fintech (Singapore) Pte. Ltd.

Verrica Pharmaceuticals Inc.

0.4905
+0.01132.36%
Post-market: 0.4701-0.0204-4.16%19:11 EDT
Volume:374.60K
Turnover:175.89K
Market Cap:45.02M
PE:-0.33
High:0.4905
Open:0.4670
Low:0.4369
Close:0.4792
Loading ...

Analysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF) and Verrica Pharmaceuticals (VRCA)

TIPRANKS
·
07 Apr

BRIEF-Verrica Pharmaceuticals Reports Strong Demand-Led Growth In Ycanth® In Q1 2025

Reuters
·
07 Apr

Verrica Pharmaceuticals Reports Strong Demand-Led Growth in Ycanth® Dispensed Applicator Units in First Quarter 2025

THOMSON REUTERS
·
07 Apr

Verrica Pharmaceuticals Reports Strong Demand-Led Growth in YCANTH® Dispensed Applicator Units in First Quarter 2025

GlobeNewswire
·
07 Apr

RBC Capital Sticks to Their Hold Rating for Verrica Pharmaceuticals (VRCA)

TIPRANKS
·
05 Apr

Verrica Pharmaceuticals Appoints Gavin Corcoran, M.d. to Its Board of Directors

THOMSON REUTERS
·
03 Apr

Press Release: Verrica Pharmaceuticals Appoints Gavin Corcoran, M.D. to its Board of Directors

Dow Jones
·
03 Apr

Here's Why Verrica Pharmaceuticals (VRCA) Is a Great 'Buy the Bottom' Stock Now

Zacks
·
01 Apr

Press Release: Verrica Pharmaceuticals Appoints Noah L. Rosenberg, M.D., as Chief Medical Officer

Dow Jones
·
26 Mar

Verrica Pharmaceuticals Inc (VRCA) Q4 2024 Earnings Call Highlights: Revenue Growth and ...

GuruFocus.com
·
12 Mar

Verrica Pharmaceuticals Inc. (VRCA) Reports Q4 Loss, Lags Revenue Estimates

Zacks
·
12 Mar

Verrica Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
12 Mar

Verrica Pharmaceuticals Inc Files for Mixed Shelf of up to $150 Mln - SEC Filing

THOMSON REUTERS
·
12 Mar

Verrica Pharmaceuticals Q4 2024 Adj. EPS $(0.18) Beats $(0.26) Estimate, Sales $344.000K Miss $1.041M Estimate

Benzinga
·
12 Mar

Corrected-Verrica Pharmaceuticals Q4 Collaboration Revenue USD 29 Thousand (Corrects Amount)

THOMSON REUTERS
·
12 Mar

Verrica Pharmaceuticals Q4 Basic EPS USD -0.24

THOMSON REUTERS
·
12 Mar

Verrica Pharmaceuticals Q4 Collaboration Revenue USD 315 Thousand

THOMSON REUTERS
·
12 Mar

Verrica Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire
·
12 Mar

Verrica Pharmaceuticals Inc expected to post a loss of 26 cents a share - Earnings Preview

Reuters
·
07 Mar

Verrica Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results and Provide a Corporate Update on March 11, 2025

GlobeNewswire
·
03 Mar